Clarient Diagnostics has licensed cancer biomarker; NASA-sponsored bone test could spot osteoporosis and cancer;

> Arterial spin labeling (ASL) MRI, which measures cerebral blood flow, could act as a biomarker in Alzheimer's disease. Abstract

> GE Healthcare ($GE) company Clarient Diagnostic Services has licensed a genetic test for the cancer biomarker ALK (anaplastic lymphoma kinase) from Insight Genetics. Press release

> Israeli researchers have found American Indians with Jewish genetic markers; a group of Indians from the state of Colorado have the "Ashkenazi mutation" on the BRCA1 gene. News

> DNA methylation detected in the blood is linked with breast cancer. Abstract

> A NASA-sponsored bone biomarker test could spot osteoporosis and cancer. Story

> Quest Diagnostics has launched a test panel to help to detect thyroid cancer. Press release

> An immune system biomarker may be able to predict early death. Article

> Genetic mutation predicts heart disease. Report

> Protein phosphatase 4 levels correlate with poor prognosis in patients with stage II pancreatic ductal adenocarcinoma. Abstract

And Finally… New York University College of Dentistry has got a share of a $20.7 million NIH grant to find biomarkers for fighting periodontal disease. Press release

Suggested Articles

The FDA has authorized its first COVID-19 antibody test for use in doctors' offices, urgent care centers and emergency rooms.

The clinical testing giant LabCorp will now begin rolling out a blood test for lung cancer developed by Resolution Bioscience.

Cognoa aims to equip pediatricians with an AI-powered app that can spot the signs of autism, allowing them to diagnose in the doctor's office.